Valeant, Exact Sciences & more — 4 GI company key notes

Here are four updates on GI companies from the past week:

Valeant reported net revenues of $2.21 billion in the third quarter of fiscal year 2017.

Exact Sciences is building a second laboratory facility in Madison, Wis., to meet growing demand for the company's Cologuard test. The company also announced it would serve as the title sponsor of the Cologuard Classic, a PGA Tour Champions event in Tucson, Ariz.

Lumendi made its DiLumen Ig Endolumenal Interventional Grasper available in the U.S.

The last patient enrolled in Immuron's IMM-124E phase II study completed their final visit. Results from the trial could be available as soon as the first quarter of 2018.

More articles on gastroenterology: 
GI leader to know: Dr. Thomas Ma of Penn State College
U of New Mexico to award Presidential Award of Distinction to Dr. Robert Strickland — 3 insights
Stock market week-in-review for 5 large GI companies — Nov. 6-10

© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months